IQVIA Holdings Inc. Analysts Recommend 'Moderate Buy'

IQVIA Holdings Inc. (NYSE:IQV - Get Free Report) has received an average recommendation of "Moderate Buy" from the 19 research firms currently covering the stock, as reported by Marketbeat Ratings. This assessment includes four analysts advising to hold the stock, fourteen recommending a buy, and one giving a strong buy rating. The consensus target price for IQVIA among these analysts stands at $256.50 for the next twelve months.

Recently, several equity research analysts have shared their views on IQV shares. For instance, JPMorgan Chase & Co. has reduced their price target for IQVIA from $279.00 to $240.00 while maintaining an "overweight" rating in their research note dated November 5th. Another firm, Redburn Atlantic, initiated coverage on IQVIA on October 14th, declaring a "buy" rating with a price target of $276.00.

In contrast, StockNews.com downgraded IQVIA from a "buy" to a "hold" rating in a report published on November 28th. Meanwhile, Morgan Stanley adjusted their target price from $280.00 to $265.00 and reiterated an "overweight" outlook in their note on November 4th. Additionally, Evercore ISI cut their price target from $270.00 to $265.00 while maintaining an "outperform" rating in a report released on October 8th.

IQVIA Stock Performance

On Friday, shares of IQVIA opened at $202.63. The company has a 50-day moving average of $215.18 and a 200-day moving average of $225.14. Financially, IQVIA shows a quick ratio of 0.81, a current ratio of 0.81, and a debt-to-equity ratio of 1.76, indicating its leverage position. The firm is valued at a market capitalization of $36.78 billion, with a price-to-earnings ratio of 26.59 and a price-to-earnings-growth ratio of 2.06. Over the past year, IQVIA's stock has reached a low of $187.62 and a high of $261.73.

Institutional Trading in IQVIA

Recently, several institutional investors and hedge funds have made moves regarding IQVIA shares. For instance, Opal Wealth Advisors LLC purchased a new stake in the company during the second quarter, valued at around $27,000. Similarly, Capital Performance Advisors LLP and Park Place Capital Corp acquired new positions in IQVIA during the third quarter, both valued at about $27,000 and $28,000, respectively. Itau Unibanco Holding S.A. and International Assets Investment Management LLC have also made investments worth approximately $29,000 and $32,000 in IQVIA lately. Overall, 89.62% of IQV's shares are owned by institutional investors and hedge funds.

About IQVIA

IQVIA Holdings Inc. specializes in providing advanced analytics, technology solutions, and clinical research services to the life sciences industry across the Americas, Europe, Africa, and the Asia-Pacific region. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

IQVIA, Stocks, Investment